M600 Innovation Hub: A space for life-science companies

Originally developed by CSL as part of its long-standing Marburg operations, the M600 R&D Campus is opening its doors to new tenants and evolving into an open-innovation environment for a broader life-science community.

Laboratory, technical, and office space is available now - for biotech companies, research organisations, CROs, CDMOs, and innovation-driven businesses looking to establish themselves in an operating biopharmaceutical environment.

Hero Image_web_m600_outside

  • 40000 m2

    of laboratory, technical & office space

  • 7,800 m2

    of laboratory space across five areas

  • BSL-1-3

    biosafety levels, plus separate pilot plant

  • .

    .

  • 7,200

    life-science professionals in the cluster

  • .

    .

Image 1 RIGHT_A Curated Multi-Tenant Campus

A curated multi-tenant campus

Unlike a conventional multi-tenant building, M600 is being curated for strategic fit across its tenants. It brings together academia, start-ups, CROs/CDMOs and biopharmaceutical companies, so that scientists and industry experts work side by side within the same building and across the campus.

The full development chain, on one campus

M600 gives tenants direct access to capabilities that would otherwise require significant time and capital to build independently.

Early-stage research
Stage 1		 Access to technical platforms and laboratories from day one.
IND/IMPD readiness
Stage 2		 Preclinical development through to regulatory submission readiness
Pilot-scale
Stage 3		 Production-scale development in the separate on-site pilot plant.
GMP scale-up
Stage 4		 GMP manufacturing potential on campus, without outsourcing.

Within Europe's pandemic-preparedness cluster

Marburg has been a centre for infectious-disease research for over half a century. Around 7,200 life-science professionals work in the surrounding Pharma & Life Science Park.

Image 2_LEFT_Infrastructure that lets you focus on the science

Infrastructure that lets you focus on the science

The laboratory area covers biosafety levels BSL-1 to BSL-3, with a separate pilot plant supporting clinical-scale research. Full on-site facility management - including pharma-specific services, site security, and environmental management - is in place, so incoming organisations can focus on science immediately.

For tenants, this means access not only to infrastructure, but to an established network of peers, suppliers, and potential collaborators - the environment in which early-stage research can scale faster.

Available space

Office & laboratory space in the R&D campus available now, divisible into smaller units, commission-free and accessible. Rents and square meters on request.

Facilities & data

Total usable area 40,000 m2
Laboratory space 7,800 m,2 divided into five areas (G2-G6)
Safety classification GenTSV S1/S2 · biosafety BSL-1 to BSL-3
Pilot plant Separate pilot plant for plasma products, production-scale
Availability Short-term · divisible into smaller units

 

On-site services

  • Full facility management
  • Laboratory services and pharma-specific expertise
  • Site security and on-site fire brigade
  • Environmental management and waste handling
  • Flexible office space with app-bookable workstations
  • Conference rooms, cafeteria and quiet zones